Hocevar M - Search Results

1

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma.

Gornjec A, Novakovic S, Stegel V, Hocevar M, Pohar Marinsek Z, Gazic B, Krajc M, Skof E. Gornjec A, et al. Among authors: hocevar m. BMC Cancer. 2019 Apr 2;19(1):296. doi: 10.1186/s12885-019-5535-2. BMC Cancer. 2019. PMID: 30940100 Free PMC article. Clinical Trial.

2

Detection of tyrosinase mRNA by an optimised nested RT-PCR in the peripheral blood of patients with advanced malignant melanoma.

Glumac N, Hocevar M, Snoj M, Novakovic S. Glumac N, et al. Among authors: hocevar m. J Exp Clin Cancer Res. 2001 Dec;20(4):529-36. J Exp Clin Cancer Res. 2001. PMID: 11876547

3

Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.

Novakovic S, Hocevar M, Zgajnar J, Besic N, Stegel V. Novakovic S, et al. Among authors: hocevar m. Oncol Rep. 2004 Jan;11(1):245-52. Oncol Rep. 2004. PMID: 14654933

4

Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.

Glumac N, Snoj M, Hocevar M, Novakovic S. Glumac N, et al. Among authors: hocevar m. Neoplasma. 2006;53(1):9-14. Neoplasma. 2006. PMID: 16416006

5

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.

Krajc M, Teugels E, Zgajnar J, Goelen G, Besic N, Novakovic S, Hocevar M, De Grève J. Krajc M, et al. Among authors: hocevar m. BMC Med Genet. 2008 Sep 10;9:83. doi: 10.1186/1471-2350-9-83. BMC Med Genet. 2008. PMID: 18783588 Free PMC article.

6

Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.

Peric B, Cerkovnik P, Novakovic S, Zgajnar J, Besic N, Hocevar M. Peric B, et al. Among authors: hocevar m. BMC Med Genet. 2008 Sep 19;9:86. doi: 10.1186/1471-2350-9-86. BMC Med Genet. 2008. PMID: 18803811 Free PMC article.

7

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.

Stegel V, Krajc M, Zgajnar J, Teugels E, De Grève J, Hočevar M, Novaković S. Stegel V, et al. Among authors: hocevar m. BMC Med Genet. 2011 Jan 14;12:9. doi: 10.1186/1471-2350-12-9. BMC Med Genet. 2011. PMID: 21232165 Free PMC article.

8

BRCA1/2 status and clinicopathologic characteristics of patients with double primary breast and ovarian cancer.

Cvelbar M, Hocevar M, Vidmar G, Teugels E. Cvelbar M, et al. Among authors: hocevar m. Neoplasma. 2011;58(3):198-204. doi: 10.4149/neo_2011_03_198. Neoplasma. 2011. PMID: 21391735

9

Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma.

Peric B, Zagar I, Novakovic S, Zgajnar J, Hocevar M. Peric B, et al. Among authors: hocevar m. BMC Cancer. 2011 Aug 2;11:328. doi: 10.1186/1471-2407-11-328. BMC Cancer. 2011. PMID: 21810220 Free PMC article.

10

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families.

Novaković S, Milatović M, Cerkovnik P, Stegel V, Krajc M, Hočevar M, Zgajnar J, Vakselj A. Novaković S, et al. Among authors: hocevar m. Int J Oncol. 2012 Nov;41(5):1619-27. doi: 10.3892/ijo.2012.1595. Epub 2012 Aug 21. Int J Oncol. 2012. PMID: 22923021 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters